Tracking the Evolution of Non–Small-Cell Lung Cancer

Mariam Jamal‐Hanjani, Gareth A. Wilson, Nicholas McGranahan, +79

New England Journal of Medicine

Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution

Nicholas McGranahan, Rachel Rosenthal, Crispin T. Hiley, +218

Cell

Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

Samra Turajlic, Kevin Litchfield, Hang Xu, +17

The Lancet Oncology

Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal

Samra Turajlic, Hang Xu, Kevin Litchfield, +46

Cell

Tumor BiologyMetastatic CcrccUrologyGenitourinary CancerTumor Heterogeneity +11

Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal

Samra Turajlic, Hang Xu, Kevin Litchfield, +67

Cell

Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal

Thomas J. Mitchell, Samra Turajlic, Andrew Rowan, +44

Cell

Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors

Frederick Arce Vargas, Andrew J.S. Furness, Isabelle Solomon, +245

Immunity

Pervasive chromosomal instability and karyotype order in tumour evolution

Thomas B.K. Watkins, Emilia L. Lim, Marina Petković, +52

Nature

Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

Lewis Au, Emine Hatipoglu, Marc Robert de Massy, +62

Cancer Cell

A CRISPR/Cas9-Engineered <i>ARID1A</i> -Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation

Yuan‐Hung Lo, Kevin S. Kolahi, Yuhong Du, +20

Cancer Discovery